A Randomized, Double-Blind, Pharmacokinetic Similarity Study to Compare AVT32-DRL_PB with Keytruda® in Participants with Fully Resected Melanoma (AVT32-DRL-TPK-02).

计划入组 24 人 · 首次发布于 2026 年 7 月 31 日

Pharmacokinetic Similarity Study to Compare AVT32-DRL_PB With Keytruda® in Participants With Fully Resected Melanoma

计划入组 120 人 · 首次发布于 2026 年 3 月 16 日

PK, Safety and Tolerability Study of AVT02 (Adalimumab) Pre-filled Syringe (PFS) vs, AVT02 Autoinjector (AI)

计划入组 207 人 · 首次发布于 2019 年 6 月 12 日

AVA32-02

Alvotech Reports Record First Half 2025 Results with Over 200% Product Revenue Growth

Alvotech's Xolair Biosimilar AVT23 Achieves Positive Phase III Results and UK Regulatory Acceptance